Healthcare
Live Price
Offline$0.60
+0.00% today
1Y Change
+138.50%
Window
Jun 23, 2025 → Jun 8, 2026
Coverage: 241 bars · Jun 23, 2025 → Jun 8, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sky Century Investment, Inc. (SKYI) is a Healthcare stock with listed on OTC. The stock last traded around $0.60 and up 138.5% across the available one-year price window (Jun 23, 2025 → Jun 8, 2026). Baseline metrics include revenue growth of +147.0%, EPS growth of +37.5%, a dividend yield of 0.0%. What stands out right now is revenue +147.0%, EPS +37.5%, free cash flow +391.7% with operating margin -59.9% and ROIC 23.1%. Valuation is more restrained than many high-expectation growth names at price/sales 4.0. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines SKYI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SKYI
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SKYI Max Drawdown
-84.59%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SKYI and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$76.8K
+25.8% YoY
FY Net Income
-$5.3K
+97.5% YoY
Free Cash Flow
-$20.3K
+63.5% YoY
Revenue Growth
+147.0%
EPS Growth
+37.5%
Gross Margin
49.8%
Net Margin
-59.9%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 76K | 31K | 75K | 61K | 77K |
| Gross Profit | 24K | -69K | -8K | -5K | 68K |
| Operating Income | -117K | -172K | -194K | -215K | -5K |
| EBITDA | -65K | -73K | -111K | -158K | -5K |
| Net Income | -117K | -172K | -194K | -212K | -5K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 11K | 0 | 0 | 375 | 2K |
| Total Assets | 124K | 54K | 150K | 289K | 201K |
| Total Liabilities | 374K | 237K | 241K | 518K | 278K |
| Shareholder Equity | -250K | -183K | -91K | -229K | -77K |
| Total Debt | 121K | 0 | 81K | 100K | 0 |
| Net Debt | 110K | 0 | 81K | 99K | -2K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
20K
+63.5% YoY
Capital Expenditures
0
Free Cash Flow
20K
+63.5% YoY
Key ratios
Gross Margin
49.8%
Operating Margin
-59.9%
Net Margin
-59.9%
ROE
24.6%
Debt / Equity
0.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.